Skip to content

Clinical trials

Observational Lymphoma, Follicular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Observational Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20111
20131
20173
20201
20221
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Not yet recruiting3
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China-Japan Friendship Hospital2
China Three Gorges University, Yichang, China1
Institute of Hematology & Blood Diseases Hospital, China1
Mundipharma (China) Pharmaceutical Co. Ltd1
National Cancer Institute (NCI)1
Peking Union Medical College Hospital1
Peking University1
Ruijin Hospital1
Samsung Medical Center1
Shanghai Ming Ju Biotechnology Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular15
Lymphoma3
Alzheimer Disease1
Cancer Pain1
Dementia1
Dementia, Vascular1
Disease Progression1
Hepatitis B1
Hodgkin Disease1
Ischemic Stroke1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.